Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Igc Pharma Inc (IGC)

Igc Pharma Inc (IGC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Igc Pharma Inc 10224 FALLS ROAD POTOMAC MD 20854 USA

https://igcpharma.com Employees: 67 P: 301-983-0998

Description:

IGC Pharma Inc. develops advanced cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome and chronic pain. IGC Pharma Inc., formerly known as India Globalization Capital Inc., is based in POTOMAC, Md.

Key Statistics

Overview:

Market Capitalization, $K 28,617
Enterprise Value, $K 27,557
Shares Outstanding, K 77,449
Annual Sales, $ 1,350 K
Annual Net Income, $ -13,000 K
Last Quarter Sales, $ 410 K
Last Quarter Net Income, $ -1,720 K
EBIT, $ -9,330 K
EBITDA, $ -8,690 K
60-Month Beta 1.29
% of Insider Shareholders 31.48%
% of Institutional Shareholders 3.87%
Float, K 53,068
% Float 68.52%
Short Volume Ratio 0.27

Growth:

1-Year Return 22.33%
3-Year Return -62.16%
5-Year Return -41.35%
5-Year Revenue Growth -73.63%
5-Year Earnings Growth -69.23%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.02 on 11/12/24
Next Earnings Date 02/12/25
Earnings Per Share ttm -0.18
EPS Growth vs. Prev Qtr 33.33%
EPS Growth vs. Prev Year 60.00%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

IGC Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -158.95%
Return-on-Assets % -119.35%
Profit Margin % -962.96%
Debt/Equity 0.02
Price/Sales 21.52
Price/Cash Flow N/A
Price/Book 3.83
Book Value/Share 0.10
Interest Coverage -0.92
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar